Neoadjuvant cisplatin for advanced bladder cancer
Author:
- Advanced Bladder Cancer Meta-analysis CollaborationACAdvanced Bladder Cancer Meta-analysis Collaboration
- 15 June 2011
- journal article
- retraction
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2011 (6) , CD001426
Abstract
The authors of this review have indicated it has been superceded by the review " Neoadjuvant chemotherapy for invasive bladder cancer" and has been withdrawn.Keywords
This publication has 16 references indexed in Scilit:
- Original Articles: Bladder Cancer: Neoadjuvant Cisplatin Chemotherapy Before Radical Cystectomy in Invasive Transitional Cell Carcinoma of the Bladder: A Prospective Randomized Phase III StudyJournal of Urology, 1995
- Does neoadjuvant cisplatin‐based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta‐analysis of individual patient data from randomized clinical trials*British Journal of Urology, 1995
- Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized StudyScandinavian Journal of Urology and Nephrology, 1993
- Meta-analysis of the literature or of individual patient data: is there a difference?The Lancet, 1993
- Neo‐adjuvant (Pre‐emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the BladderBritish Journal of Urology, 1991
- Combined modality treatment with radiotherapy and chemotherapyRadiotherapy and Oncology, 1989
- Neoadjuvant chemotherapy for invasive bladder cancerSeminars in Surgical Oncology, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982